Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

ClinicalTrials.gov ID: NCT05462756

Public ClinicalTrials.gov record NCT05462756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Parallel-Design, Open-Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adults With Type 2 Diabetes on Multiple Daily Injections

Study identification

NCT ID
NCT05462756
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
730 participants

Conditions and interventions

Interventions

  • Insulin Efsitora Alfa Drug
  • Insulin Glargine (U100) Drug
  • Insulin Lispro (U100) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2022
Primary completion
Feb 26, 2024
Completion
Feb 26, 2024
Last update posted
Apr 26, 2025

2022 – 2024

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
CMR of Greater New Haven, LLC Hamden Connecticut 06517
Tampa Bay Medical Research Clearwater Florida 33761
Panax Clinical Research Miami Lakes Florida 33014
Encore Medical Research - Weston Weston Florida 33331
Elite Clinical Trials Blackfoot Idaho 83221
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
MedStar Good Samaritan Hospital Baltimore Maryland 21239
NECCR PrimaCare Research Fall River Massachusetts 02721
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Sunset Las Vegas Nevada 89148
Research Foundation of SUNY - University of Buffalo Buffalo New York 14221
Remington Davis Clinical Research Columbus Ohio 43215
Aventiv Research Dublin Ohio 43016
Heritage Valley Multispecialty Group, Inc Beaver Pennsylvania 15009
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731
Texas Diabetes & Endocrinology, P.A. Austin Texas 78749
North Texas Endocrine Center Dallas Texas 75231
Biopharma Informatic, LLC Houston Texas 77043
Research Institute of Dallas Plano Texas 75093
Consano Clinical Research, LLC Shavano Park Texas 78231
Chrysalis Clinical Research St. George Utah 84790
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05462756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05462756 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →